PRAC Starts Safety Review of Remdesivir PRAC Starts Safety Review of Remdesivir

A ' safety signal ' of acute kidney injury in patients with COVID-19 taking remdesivir prompts the European Medicines Agency to launch a review.News Alerts

Source: Medscape Infectious Diseases Headlines - October 2, 2020 Category: Infectious Diseases Tags: Nephrology News Alert Source Type: news